-

Replacement Reference Rate for U.S. Law-Governed U.S. Dollar LIBOR-Linked Preferred Stock and Debt Securities

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) is issuing this press release to advise that the three-month U.S. dollar LIBOR in the U.S. law-governed U.S. dollar LIBOR-linked preferred stock and debt securities specified below (the “Specified Instruments”) issued by MetLife, Inc. (“MetLife”) and MetLife Capital Trust IV, as applicable, will be replaced with the CME Term SOFR Reference Rate published for a three-month tenor plus a spread adjustment of 0.26161%, effective for determinations made under the terms of the Specified Instruments after June 30, 2023 (the “Cessation Date”), when the relevant U.S. dollar LIBOR settings are expected to either cease publication or no longer be representative but will not affect any determinations made on or prior to the Cessation Date.

MetLife Issued Preferred Stock

 

CUSIP

Description

 

59156R504*

Floating Rate Non-Cumulative Preferred Stock, Series A

59156RBT4*

Fixed-to-Floating Rate Non-Cumulative Preferred Stock, Series D

 

MetLife and MetLife Capital Trust IV Issued Debt Securities

 

CUSIP

Description

 

59156RAP3*

MetLife Fixed-to-Floating Rate Junior Subordinated Debentures due 2066

591560AA5*

MetLife Capital Trust IV Fixed-to Floating Rate Exchangeable Surplus Trust Securities exchangeable under certain circumstances into a like amount of MetLife Fixed-to-Floating Rate Junior Subordinated Debentures due 2067

59156RBS6*

MetLife Fixed-to-Floating Rate Junior Subordinated Debentures due 2068

59156RAV0*

MetLife Fixed-to-Floating Rate Junior Subordinated Debentures due 2069

 

* The CUSIP number is included solely for the convenience of the holders of the Specified Instruments. No paying agent, trustee or transfer agent shall be responsible for the selection or use of the CUSIP number, nor is any representation made as to its correctness on the Specified Instruments or as indicated in this press release.

About MetLife

MetLife, Inc. (NYSE: MET), through its subsidiaries and affiliates (“MetLife”), is one of the world’s leading financial services companies, providing insurance, annuities, employee benefits and asset management to help individual and institutional customers build a more confident future. Founded in 1868, MetLife has operations in more than 40 markets globally and holds leading positions in the United States, Japan, Latin America, Asia, Europe and the Middle East. For more information, visit www.metlife.com.

Contacts

For Media:
Brian Blaser
212-578-2415
bblaser@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

MetLife, Inc.

NYSE:MET

Release Summary
REPLACEMENT REFERENCE RATE FOR U.S. LAW-GOVERNED U.S. DOLLAR LIBOR-LINKED PREFERRED STOCK AND DEBT SECURITIES
Release Versions

Contacts

For Media:
Brian Blaser
212-578-2415
bblaser@metlife.com

For Investors:
John Hall
212-578-7888
John.A.Hall@metlife.com

More News From MetLife, Inc.

MetLife Study Finds AI Acceleration Is Creating New Concerns in Today’s Workplace

NEW YORK--(BUSINESS WIRE)--As the adoption of artificial intelligence (AI) in the workplace accelerates, MetLife’s 24th Annual U.S. Employee Benefit Trends Study (EBTS) reveals, alongside other findings, a workforce both optimistic about the technology’s efficiency gains and concerned about how technological change is reshaping work, well‑being and long‑term security. MetLife’s 2026 EBTS, released today, shows that AI is already deeply embedded in everyday work: 80% of employers say AI tools ar...

MetLife Recommends Shareholders Reject “Mini-Tender” Offer by Potemkin Limited

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has received notice of an unsolicited mini-tender offer by Potemkin Limited (“Potemkin”) to purchase up to 10,000 shares of MetLife, Inc. common stock from MetLife shareholders. The offer is for approximately 0.002 percent of MetLife shares of common stock outstanding as of February 12, 2026. Potemkin’s offer price of $51.60 per share is approximately 27.09 percent lower than the $70.77 closing price of MetLife common...

MetLife Confirms First Quarter 2026 Series A Preferred Stock Dividend

NEW YORK--(BUSINESS WIRE)--MetLife, Inc. (NYSE: MET) today announced that it has confirmed its previously announced declaration of the first quarter 2026 dividend of $0.31501229 per share on the company’s floating rate non-cumulative preferred stock, Series A, with a liquidation preference of $25 per share (NYSE: MET PRA). The New York Stock Exchange has not yet set an ex-dividend date for the Series A preferred stock. Following this confirmatory announcement, the New York Stock Exchange will s...
Back to Newsroom